|
1
|
Kaushik AP, Das A and Cui Q: Osteonecrosis
of the femoral head: an update in year 2012. World J Orthop.
3:49–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang C, Wang Y, Meng HY, Yuan XL, Xu XL,
Wang AY, Guo QY, Peng J and Lu SB: Application of bone marrow
mesenchymal stem cells to the treatment of osteonecrosis of the
femoral head. Int J Clin Exp Med. 8:3127–3135. 2015.PubMed/NCBI
|
|
3
|
Ince A, Lermann J, Göbel S, Wollmerstedt N
and Hendrich C: No increased stem subsidence after arthroplasty in
young patients with femoral head osteonecrosis: 41 patients
followed for 1–9 years. Acta Orthop. 77:866–870. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim YH, Choi Y and Kim JS: Cementless
total hip arthroplasty with alumina-on-highly cross-linked
polyethylene bearing in young patients with femoral head
osteonecrosis. J Arthroplasty. 26:218–223. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Persiani P, De Cristo C, Graci J, Noia G,
Gurzì M and Villani C: Stage-related results in treatment of hip
osteonecrosis with core-decompression and autologous mesenchymal
stem cells. Acta Orthop Belg. 81:406–412. 2015.PubMed/NCBI
|
|
6
|
Tabatabaee RM, Saberi S, Parvizi J,
Mortazavi SM and Farzan M: Combining concentrated autologous bone
marrow stem cells injection with core decompression improves
outcome for patients with Early-Stage osteonecrosis of the femoral
head: a comparative study. J Arthroplasty 30 (Suppl 9). 11–15.
2015. View Article : Google Scholar
|
|
7
|
Sonoda K, Yamamoto T, Motomura G,
Nakashima Y, Yamaguchi R and Iwamoto Y: Outcome of
transtrochanteric rotational osteotomy for posttraumatic
osteonecrosis of the femoral head with a mean follow-up of 12.3
years. Arch Orthop Trauma Surg. 135:1257–1263. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao D, Liu B, Wang B, Yang L, Xie H,
Huang S, Zhang Y and Wei X: Autologous bone marrow mesenchymal stem
cells associated with tantalum rod implantation and vascularized
iliac grafting for the treatment of end-stage osteonecrosis of the
femoral head. Biomed Res Int. 2015:2405062015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jin H, Xu T, Chen Q, Wu C, Wang P, Mao Q,
Zhang S, Shen J and Tong P: The fate and distribution of autologous
bone marrow mesenchymal stem cells with intra-arterial infusion in
osteonecrosis of the femoral head in dogs. Stem Cells Int.
2016:86161432016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park HW, Chang JW, Yang YS, Oh W, Hwang
JH, Kim DG and Paek SH: The effect of donor-dependent
administration of human umbilical cord blood-derived mesenchymal
stem cells following focal cerebral ischemia in rats. Exp
Neurobiol. 24:358–365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu Z, Guo S, Fang G, Cui Z and Liu Y: AKT
pathway affects bone regeneration in nonunion treated with
umbilical cord-derived mesenchymal stem cells. Cell Biochem
Biophys. 2014.
|
|
12
|
Qu Z, Guo L, Fang G, Cui Z, Guo S and Liu
Y: Biological characteristics and effect of human umbilical cord
mesenchymal stem cells (hUC-MSCs) grafting with blood plasma on
bone regeneration in rats. Cell Biochem Biophys. 63:171–181. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qu Z, Fang G, Cui Z and Liu Y: Cell
therapy for bone nonunion: a retrospective study. Minerva Med.
106:315–321. 2015.PubMed/NCBI
|
|
14
|
Klimczak A and Kozlowska U: Mesenchymal
stromal cells and tissue-specific progenitor cells: their role in
tissue homeostasis. Stem Cells Int. 2016:42852152016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mattar P and Bieback K: Comparing the
immunomodulatory properties of bone marrow, adipose tissue, and
birth-associated tissue mesenchymal stromal cells. Front Immunol.
6:5602015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao D, Cui D, Wang B, Tian F, Guo L, Yang
L, Liu B and Yu X: Treatment of early stage osteonecrosis of the
femoral head with autologous implantation of bone marrow-derived
and cultured mesenchymal stem cells. Bone. 50:325–330. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mao Q, Jin H, Liao F, Xiao L, Chen D and
Tong P: The efficacy of targeted intraarterial delivery of
concentrated autologous bone marrow containing mononuclear cells in
the treatment of osteonecrosis of the femoral head: a five year
follow-up study. Bone. 57:509–516. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Association Research Circulation Osseous,
. Committee on terminology and classification. ARCO News. 4:41–46.
1992.
|
|
19
|
Harris WH: Traumatic arthritis of the hip
after dislocation and acetabular fractures: treatment by mold
arthroplasty. An end-result study using a new method of result
evaluation. J Bone Joint Surg Am. 51:737–755. 1969.PubMed/NCBI
|
|
20
|
Zhao D, Zhang Y, Wang W, Liu Y, Li Z, Wang
B and Yu X: Tantalum rod implantation and vascularized iliac
grafting for osteonecrosis of the femoral head. Orthopedics.
36:789–795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kameneva MV, Watach MJ and Borovetz HS:
Gender difference in oxygen delivery index: Potential link to
development of cardiovascular diseases. Appl Cardiopulm
Pathophysiol. 9:382–387. 2000.
|
|
22
|
Cho YI and Cho DJ: Hemorheology and
microvascular disorders. Korean Circ J. 41:287–295. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsai AG, Hofmann A, Cabrales P and
Intaglietta M: Perfusion vs. oxygen delivery in transfusion with
‘fresh’ and ‘old’ red blood cells: the experimental evidence.
Transfus Apheresis Sci. 43:69–78. 2010. View Article : Google Scholar
|
|
24
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop Dj and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Orlic D, Kajstura J, Chimenti S, Jakoniuk
I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM,
et al: Bone marrow cells regenerate infarcted myocardium. Nature.
410:701–705. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu KH, Han ZC, Mo XM and Zhou B: Cell
delivery in cardiac regenerative therapy. Ageing Res Rev. 11:32–40.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barbash IM, Chouraqui P, Baron J, Feinberg
MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, et
al: Systemic delivery of bone marrow-derived mesenchymal stem cells
to the infarcted myocardium: feasibility, cell migration, and body
distribution. Circulation. 108:863–868. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Fang J, Su H, Yang M, Lai W, Mai
Y and Wu Y: Bone marrow mesenchymal stem cells attenuate lung
inflammation of hyperoxic newborn rats. Pediatr Transplant.
16:589–598. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Molina EJ, Palma J, Gupta D, Torres D,
Gaughan JP, Houser S and Macha M: Improvement in hemodynamic
performance, exercise capacity, inflammatory profile, and left
ventricular reverse remodeling after intracoronary delivery of
mesenchymal stem cells in an experimental model of pressure
overload hypertrophy. J Thorac Cardiovasc Surg. 135:292–299,
299.e1. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Freyman T, Polin G, Osman H, Crary J, Lu
M, Cheng L, Palasis M and Wilensky RL: A quantitative, randomized
study evaluating three methods of mesenchymal stem cell delivery
following myocardial infarction. Eur Heart J. 27:1114–1122. 2006.
View Article : Google Scholar : PubMed/NCBI
|
